F+FreeMedSite USMLELearn with clinical reasoning
SEPARATE VIVA EXTENSION

Catecholaminergic polymorphic ventricular tachycardia

Follow-up oral questions and concise, clinically defensible model answers. Your MCQ remains open in its original tab.

← Return to original MCQ
EXAMINER FOLLOW-UP 1

What cellular event triggers the ventricular arrhythmia?

Catecholamine-mediated abnormal sarcoplasmic reticulum calcium release and delayed afterdepolarizations.

EXAMINER FOLLOW-UP 2

What class of therapy is commonly first-line?

Nonselective beta blockers such as nadolol, with further specialist management when indicated.

EXAMINER FOLLOW-UP 3

Is structural cardiomyopathy required for CPVT?

No; baseline cardiac anatomy and function are often normal.